Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Compliance × Leuprolide × Breast × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 24 Premenopausal Breast Cancer 2 Breast Neoplasms, Male 2 Patient Compliance 1 Hereditary Sensory and Autonomic Neuropathies 1 HER2-positive Breast Cancer 1 Breast Cancer Invasive 1

Interventions

beta-Aminoethyl Isothiourea 1 Trastuzumab 1 Surveys and Questionnaires 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Leuprolide 1 Lapatinib 1 Interviews as Topic 1 Goserelin 1 Exercise 1 Clodronic Acid 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05122377 2026-01-06

RWE About QOL and Compliance of Patients With OFS in China

Fudan University

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡